Arch Biopartners Inc.
ARCH.V
TSX
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 229.20K | 614.50K | 1.06M | 523.60K | 118.10K |
Total Receivables | 233.90K | 219.50K | 8.90K | 2.20M | 395.10K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 18.90K | 31.80K | 5.60K | 8.20K | 17.40K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 482.00K | 865.80K | 1.07M | 2.73M | 530.60K |
|
|||||
Total Current Assets | 482.00K | 865.80K | 1.07M | 2.73M | 530.60K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 482.00K | 865.80K | 1.07M | 2.73M | 530.60K |
|
|||||
Total Accounts Payable | 227.60K | 290.80K | 1.58M | 2.31M | 567.50K |
Total Accrued Expenses | 160.20K | 127.50K | 78.90K | 54.80K | 20.40K |
Short-term Debt | 1.33M | 1.27M | 408.60K | 1.11M | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.10M | 1.92M | 1.59M | 1.55M | 1.55M |
Total Finance Division Other Current Liabilities | 606.30K | 812.30K | -- | -- | -- |
Total Other Current Liabilities | 606.30K | 812.30K | -- | -- | -- |
Total Current Liabilities | 4.43M | 4.42M | 3.24M | 5.03M | 2.14M |
|
|||||
Total Current Liabilities | 4.43M | 4.42M | 3.24M | 5.03M | 2.14M |
Long-Term Debt | 378.60K | 520.40K | 2.17M | 1.71M | 1.69M |
Short-term Debt | 1.33M | 1.27M | 408.60K | 1.11M | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.81M | 4.94M | 5.42M | 6.74M | 3.83M |
|
|||||
Common Stock & APIC | 17.51M | 16.66M | 17.02M | 16.57M | 16.56M |
Retained Earnings | -21.83M | -20.74M | -21.37M | -20.58M | -19.86M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -4.33M | -4.07M | -4.35M | -4.01M | -3.30M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -4.33M | -4.07M | -4.35M | -4.01M | -3.30M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.33M | -4.07M | -4.35M | -4.01M | -3.30M |
|